Cannabis Report
Home > Boards > US Listed > Medical - Drugs >

Apricus Biosciences, Inc. (APRI)

APRI RSS Feed
Add APRI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/20/2018 6:45:46 AM - Followers: 200 - Board type: Free - Posts Today: 1

Apricus Biosciences, Inc. (APRI) 

 

 

http://www.apricusbio.com/

 

 

 

 

Company Address:

11975 El Camino Real, Suite 300
San Diego, CA 92130
T (858) 222-8041

 CIK:   0001017491

Apricus Website:    http://www.apricusbio.com/index.html

 

 
 

NexACT® - Multi-Route Drug Delivery Technology

NexACT® Multi-Route drug delivery technology facilitates compounds crossing the lipid bilayer and yet biodegrades in vivo to natural amino acids and natural fatty acids.

This technology is useful for:
  • Penetrating, proprietary, topical & transdermal formulations.
    Improving oral bioavailability of poorly soluble, poorly permeating compounds (BCS class 2-4)
    Delivering siRNA therapeutics into the cells; in vivo validated
    Development of more effective, penetrating cosmeceutic formulations
    Preservative

The safety and permeation properties of this proprietary drug delivery technology was demonstrated in the Vitaros® product which was approved for the treatment of erectile dysfunction in November 2010 by Health Canada, and approved by the European Union in June 2013.  Vitaros has been launched in all European Union countries by partner pharmaceutical companies.  Additional agreements for marketing Vitaros have been established.  For more information see the company's most recent 10K SEC filing.

In September 2015 the company anounced an agreement with Allergan to reacquire marketing rights for Vitaros in the U.S.  The company expects to resubmit a filing for FDA approval of Vitaros in the second half of 2016.  For more information see the company's most recent 10K SEC filing.


The company expects to initiate a Phase IIb clinical trial for RayVa to treat Reynaud's Syndrome in the second half of 2016.

In October 2014, the company acquired U.S. development and licensing rights to Fispemifene, a Selective Estrogen-Receptor Modulator (SERM) for treatment of secondary hypogonadism.  In March 2016 the company discontinued development Fispemifene after disappointing Phase IIb results.
.

 Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001017491&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Share Structure:
Outstanding Shares
 61,78M

Authorized Shares
75,000,000
  

Investor Relations:
ir@apricusbio.com
Tel: +1-858 222-8041

Matthew Beck
The Trout Group
:(646)378 2933

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 


                                                                           
Image result for vitaros                                                  

Image result for vitaros

Cannabis Report
APRI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
APRI News: Current Report Filing (8-k) 05/17/2018 04:43:25 PM
APRI News: Current Report Filing (8-k) 05/03/2018 04:07:19 PM
APRI News: Quarterly Report (10-q) 05/03/2018 04:06:18 PM
APRI News: Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results: 05/03/2018 04:01:23 PM
APRI News: Apricus Biosciences Provides Corporate Update and First Quarter 2018 Financial Results 05/03/2018 04:01:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#28070   ?? maybe Pascoe got lucky .... Aprilov 06/20/18 06:45:46 AM
#28069   * * $APRI Video Chart 06-19-18 * * ClayTrader 06/19/18 04:54:59 PM
#28068   Volume! Hold. aristotelisonassis 06/19/18 03:38:28 PM
#28067   long here. aristotelisonassis 06/19/18 02:59:42 PM
#28066   Share price going up to over $1.00 by Detox33 06/19/18 02:28:03 PM
#28065   * * $APRI Video Chart 06-12-18 * * ClayTrader 06/12/18 05:13:41 PM
#28064   .25 and off to the races ! CarlCarlMcB 06/12/18 09:48:04 AM
#28063   UP 12% premarket already news coming ? hebbeke47 06/12/18 05:46:06 AM
#28062   It may be a pump if so please Detox33 06/11/18 06:24:11 PM
#28061   * * $APRI Video Chart 06-11-18 * * ClayTrader 06/11/18 04:18:35 PM
#28060   There is no FDA NEWS Coming. The company Aprilov 06/11/18 04:05:11 PM
#28059   maybe positive FDA news coming soon. Holding tight overnight. aristotelisonassis 06/11/18 03:47:36 PM
#28058   Any news causing breakout Detox33 06/11/18 03:20:05 PM
#28057   breakout! Long. aristotelisonassis 06/11/18 02:25:45 PM
#28056   Item 5.07 Submission of Matters to a Vote mecosmo2 05/18/18 09:48:00 AM
#28055   1.50.. maybe Aprilov 05/16/18 12:23:38 PM
#28054   A buyout of $5.00 per share would be mecosmo2 05/16/18 12:22:24 PM
#28053   Apricus will either merge or be bought out Aprilov 05/15/18 04:52:00 PM
#28052   $1.21 by next week Detox33 05/15/18 04:12:58 PM
#28051   Picking up some today.. Like the way this #1pennytrader 05/15/18 11:14:34 AM
#28050   .08 coming CarlCarlMcB 05/14/18 01:01:45 PM
#28049   Very good news coming very soon on that front. cecilburrow 05/14/18 12:14:28 PM
#28048   Whats up? Possible sale or Partner? mecosmo2 05/11/18 01:00:25 PM
#28047   SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- mecosmo2 05/04/18 08:17:00 AM
#28046   . The raging bull 04/30/18 11:03:40 AM
#28045   I don't agree ddaip has value Aprilov 04/22/18 05:45:45 PM
#28044   The company is dead, Vitaros is dead in casinokid11211 04/22/18 08:31:13 AM
#28043   Did just that. Now what do you think Escultor 04/22/18 02:23:25 AM
#28042   I hate to agree with you !!! Aprilov 04/21/18 03:15:13 PM
#28041   The only way it is over is if casinokid11211 04/21/18 09:01:07 AM
#28040   No choice now ... It's all over Aprilov 04/16/18 08:32:56 PM
#28039   Remember John Cougar's song, "When the wall come casinokid11211 04/16/18 07:26:59 PM
#28038   * * $APRI Video Chart 04-16-18 * * ClayTrader 04/16/18 05:12:20 PM
#28037   OOPS after doing some more reading turns out PJO 04/16/18 04:35:13 PM
#28036   What is a deficiency letter ??? PJO 04/16/18 04:32:12 PM
#28035   They have no debt ... Aprilov 04/16/18 12:57:18 PM
#28034   yeah, but who would want to buy all cecilburrow 04/16/18 12:37:01 PM
#28033   market cap equals to the US rights alone shurtha2000 04/16/18 11:55:49 AM
#28032   No problem selling rights in the U.S. this shurtha2000 04/16/18 11:23:16 AM
#28031   .0001 hardly done ! CarlCarlMcB 04/16/18 11:10:38 AM
#28030   At least no more dilution ?? Aprilov 04/16/18 10:32:28 AM
#28029   Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting mecosmo2 04/16/18 09:49:26 AM
#28028   Gap Fill coming...LT PT 1.50..ST PT .85 CptChemtrail 04/14/18 12:52:37 AM
#28027   Timber CarlCarlMcB 04/09/18 07:41:36 AM
#28026   Wrong Aprilov, you Pascoe lovers will vote to casinokid11211 04/08/18 08:16:36 AM
#28025   UNITED STATES mecosmo2 04/07/18 09:41:03 AM
#28024   (4/12): Apricus Biosciences (NASDAQ:APRI): Pre-IND meeting with FDA mecosmo2 04/06/18 09:48:37 AM
#28023   Only 2 things can happen now a buyout Aprilov 04/05/18 10:14:28 AM
#28022   warrants to purchase up to an aggregate of sharky 04/05/18 09:33:13 AM
#28021   .0001 CarlCarlMcB 04/05/18 06:01:17 AM
PostSubject